Trademarkia Logo

Canada

C$
VYROLOGIX
CANCELLED

Last Applicant/ Owned by

CYTODYN INC.

Suite 660,1111 Main StreetVancouver WA 98660

US

Serial Number

2029485 filed on 10th Feb 2020

Registration Number

TMA1116997 registered on 5th Jan 2022

Registration expiry Date

10th Feb 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

VYROLOGIX

Trademark usage description

therapeutic preparations, namely, antibodies for use in targeting the c-c chemokine receptor type 5 [ccr5] cell receptor, for treating hiv, cancer, gr Read More

Classification Information


Class [005]
Therapeutic preparations, namely, antibodies for use in targeting the C-C chemokine receptor type 5 [CCR5] cell receptor, for treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis.


Classification kind code

11

Mark Details


Serial Number

2029485

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 17th Sept 2021
Approval Notice Sent
Submitted for opposition 26
on 17th Sept 2021
Approved
Submitted for opposition 22
on 13th Sept 2021
Search Recorded
Submitted for opposition 48
on 22nd Jun 2021
Agent Changed
Submitted for opposition 256
on 22nd Mar 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 21st May 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 20th May 2020
Formalized
Submitted for opposition 1
on 20th May 2020
Created
Submitted for opposition 228
on 10th Feb 2020
International Registration
Submitted for opposition 30
on 10th Feb 2020
Filed